Back to Nuveen, LLC Nuveen, LLC

FDMTFDMT
6 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in 4D MOLECULAR THERAPEUTICS IN

Nuveen, LLC holds 503,071 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $6.7M as of 2026-Q2. The position was decreased (-10.4% shares). FDMT represents 0.0% of Nuveen, LLC's portfolio.

Current Value

$6.7M

Current Shares

503,071

Total Value Change

+$6.2M

Total Shares Change

+352,757

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
503,071
-10.4%
$6.7M0.0%$13.30
0
2026-Q1
Increased
561,805
+253.8%
$5.2M0.0%$8.46
44
2025-Q4
Increased
158,769
+69.0%
$1.2M0.0%$7.58
37
2025-Q3
Decreased
93,919
-6.7%
$816,1560.0%$8.35
0
2025-Q2
Decreased
100,705
-33.0%
$373,6160.0%$3.84
0
2025-Q1
New
150,314
-
$485,5150.0%$3.63
33

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used